Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01994564

Prevalence of Dyschromatopsia in Glaucoma Patients

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Massachusetts Eye and Ear Infirmary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Glaucoma is a progressive disease resulting in loss of retinal nerve cells and their axons (retinal nerve fibers). Retinal nerve fibers are ordered in a special manner when they enter the optic nerve. Hence, damage to the retinal nerve fibers by glaucoma results in visual field defects at certain locations. Furthermore, the retinal nerve fiber layers from different receptors for different colors are ordered in a special manner as well. Thus, it is possible that glaucomatous damage causes color vision dysfunction (dyschromatopsia). At the moment there is disagreement whether dyschromatopsia occurs at early- to mid-stage or only in end-stage glaucoma. By testing color vision in glaucoma patients the prevalence of dyschromatopsia in glaucoma and in different stages of the disease will be investigated.

Conditions

Timeline

Start date
2012-11-01
Primary completion
2013-12-01
Completion
2014-01-01
First posted
2013-11-26
Last updated
2013-11-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01994564. Inclusion in this directory is not an endorsement.